As of 2025-05-16, the Fair Value of Zealand Pharma A/S (ZEAL.CO) is -75.92 DKK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 402.40 DKK, the upside of Zealand Pharma A/S is -118.87%.
With the market price of 402.40 DKK and our fair value calculation, Zealand Pharma A/S (ZEAL.CO) is not a good investment. Investing in ZEAL.CO stocks now will result in a potential loss of 118.87%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -846.73 | -1,018.15 | -1,202.14 | -703.74 | -1,078.83 | -969.92 |
| YoY growth | -48.15% | -20.24% | -18.07% | 41.46% | -53.30% | -19.66% |
| Market Cap (mil) | 28,590.52 |
| P/E | |
| Forward P/E |
| EPS | -15.18 |
| Avg earnings growth rate | -19.66% |
| TTM earnings | -1,078.83 |